Shandong Sito Bio-technology Co., Ltd. (SHE:300583)
China · Delayed Price · Currency is CNY 17.96
+0.16 (0.90%)
Jul 16, 2025, 2:45 PM CST
Shandong Sito Bio-technology Company Description
Shandong Sito Bio-technology Co., Ltd. researches, develops, and produces steroid biomedicine intermediates.
Its products include 9α-hydroxyandrost, 17α-hydroxyprogesterone, 17α-hydroxy progesterone derivatives, anecort acetate, neomycin sulfate, progesterone intermediate, tylvalosin tartrate, tetraene acetate, androstenedione, bisnoralcohol, norandrostenedione, ethylene deltenone, 16β and 16α methyl epoxide, and hexahydro-3a-methyl, as well as androsta-1,4-diene-3,17-dione and estra-4,9-diene-3,17-dione.
The company was founded in 2002 and is based in Heze City, China.
Shandong Sito Bio-technology Co., Ltd.
| Country | China |
| Founded | 2002 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 959 |
| CEO | Lianbiao Jin |
Contact Details
Address: South section of East Outer Ring Road, Heze City, 274100 China | |
| Phone | 86 53 0226 3536 |
| Website | sitobiotech.com |
Stock Details
| Ticker Symbol | 300583 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100002F36 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Lianbiao Jin | General Manager |
| Fuwen Li | Chief Financial Officer |
| Lu Li | Deputy GM, Board Secretary and Director |
| Yong Hong Wang | Accounting Supervisor |